We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Duchenne Muscular Dystrophy Treatable with Modified Gene Engineering Therapy

By LabMedica International staff writers
Posted on 17 Jun 2013
Print article
Image: The TALEN finds its target site in the human genome by binding to DNA, shown in green, with an engineered DNA-recognition protein, shown in orange. Once the protein finds its target site, the DNA is modified by the enzyme domain of the protein shown in blue (Photo courtesy of Dr. Charles Gersbach, Duke University).
Image: The TALEN finds its target site in the human genome by binding to DNA, shown in green, with an engineered DNA-recognition protein, shown in orange. Once the protein finds its target site, the DNA is modified by the enzyme domain of the protein shown in blue (Photo courtesy of Dr. Charles Gersbach, Duke University).
A team of biomedical engineers has demonstrated the potential for curing Duchenne muscular dystrophy (DMD) with modified gene editing therapy that does not require a DNA repair template.

DMD is caused by mutations in the gene that encodes the protein dystrophin and the subsequent disruption of the dystrophin-associated protein complex (DAPC). The mutation occurs on the X-chromosome, and the disease effects about one of every 3,500 boys whose muscle function is so degraded that they die usually before reaching the age of 30.

Having based their experiments on the premise that many genetic diseases could be treated simply by correcting a disrupted DNA reading frame, investigators at Duke University (Durham, NC, USA) recently reported that genome editing with transcription activator-like effector nucleases (TALENs), without a repair template, could efficiently correct the reading frame and restore the expression of a functional dystrophin protein.

Restriction enzymes are enzymes that cut DNA strands at a specific sequence. TALENs can be engineered to bind practically any desired DNA sequence, and by combining such an engineered TALEN with a DNA cleavage domain (which cuts DNA strands), one is able to engineer restriction enzymes that are specific for any desired DNA sequence. When these restriction enzymes are introduced into cells, they can be used for genome editing in situ, a technique known as genome editing with engineered nucleases.

The Duke University investigators engineered a TALEN gene to mediate highly efficient gene editing at exon 51 of the dystrophin gene. The gene was inserted into plasmids, and the plasmids were used to transfect target cells including skeletal myoblasts and dermal fibroblasts. The TALENs were then used to edit the genome by inducing double-strand breaks (DSB), to which the cells responded with repair mechanisms.

Results published in the June 4, 2013, online edition of the journal Molecular Therapy revealed that genome editing with TALENs, but without a repair template, could efficiently correct the reading frame and restore the expression of functional dystrophin protein that had been mutated in DMD.

"Conventional genetic approaches to treating the disease involve adding normal genes to compensate for the mutated genes," said senior author Dr. Charles Gersbach, assistant professor of biomedical engineering at Duke University. "However, this can cause other unforeseen problems, or the beneficial effect does not always last very long. Our approach actually repairs the faulty gene, which is a lot simpler. It finds the faulty gene and fixes it so it can start producing a functional protein again."

"Similar approaches could be helpful in treating other genetic diseases where a few gene mutations are responsible, such as sickle cell disease, hemophilia, or other muscular dystrophies," said Dr. Gersbach.

Related Links:
Duke University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.